Used in pharmaceutical research as a potent and selective inhibitor of soluble epoxide hydrolase (sEH), this compound is investigated for its anti-inflammatory and analgesic properties. It shows potential in treating neuropathic pain and inflammatory conditions by stabilizing endogenous epoxy fatty acids, which have natural anti-inflammatory effects. Due to its ability to cross the blood-brain barrier, it is also explored for central nervous system disorders. Preclinical studies suggest benefits in models of chronic pain, diabetes-related complications, and cardiovascular diseases. Its role in modulating pain pathways without opioid mechanisms makes it a candidate for non-addictive pain therapies.